BioTransfer 2009
|
Contacts
Co-organizers Technology Portfolio
Co-organizers
NRC Biotechnology Research Institute (NRC-BRI)
NRC Institute for Biological Sciences (NRC-IBS)
McGill University and the Research Institute of the McGill University Health Centre
Montreal Excellerator
Gestion Univalor, Limited Partnership
Université de Montréal and Affiliated Hospital Centres
The Massachusetts Technology Transfer Center
Co-organizers Technology Portfolio Login
The Massachusetts Technology Transfer Center
Technology Portfolio
ID #
Title
PDF
Video
Information Request
MTTC-UMassMed
Novel HIV-1 Protease Inhibitors
MTTC-Tufts
Atoxic Recombinant Holotoxins of Clostridium Difficile as Immunogens
MTTC-Harvard
Platform Technology for Small Molecule Modulators of Autophagy
MTTC-Children's
Lodamin: a novel oral drug for oncology, ophthalmology and autoimmune diseases
MTTC-Broad
Gene-expression signatures that identify cirrhosis patients "at risk" for liver cancer and predict the probability of HCC recurrence following early-stage diagnosis and resection
MTTC-Brigham
Novel HSV2 Vaccine Technology
MTTC-6
Angiogenin as a Potential Therapy for ALS
MTTC-5
Extract-based Functional Assay (EFA) for the Detection of Post-Translational Modifications
MTTC-4
Detection of Solid Tumor Signatures in Blood of Cancer Patients
MTTC-3
High-Throughput Screening Tools for Disruptors of Meiosis and Fat Homeostasis
MTTC- Whitehead
Expansion of Hematopoeitic Stem Cells
Date Modified: 2009-12-04